Boston CEO 2026
Boston CEO brings BioPharma executives together for discussions and networking.
Mandarin Oriental, Boston
- Date
- November 2, 2026
- Venue
- Mandarin Oriental, Boston
Who you'll find in the room
BioPharma CEOs
BioPharma CEOs are among the audience groups identified by the organizer.
Research and development leaders
The organizer identifies heads of research and development as an audience group.
Life science investors
Life science investors are identified as an audience group.
Academics
The organizer identifies leading academics as an audience group.
Featured speakers
76 listedMaura Healey
Governor Massachusetts
Michelle Wu
Boston Mayor
George Yancopoulos
CSO, Regeneron
Fiona Marshall
President, NIBR
Sally Kornbluth
President, MIT
Robert Plenge
Chief Research Officer, BMS
Marc Casper
CEO Thermo Fisher Scientific
Anne Klibanski
CEO Mass General Brigham
Bob Langer
Scientific Founder Moderna
Mathai Mammen
CEO, Parabilis Medicines former Head, R&D, J&J
Thomas Schinecker
CEO Roche
Phil Sharp
Scientific Founder Alnylam/Biogen
Priya Singhal
EVP, Head, Development Biogen
Christoph Westphal
General Partner Longwood Fund
Laurent Levy
CEO Nanobiotix
Mathai Mammen
CEO, Parabilis Medicines
Bill Meury
CEO Incyte
Stefan Oelrich
CEO Bayer Pharmaceuticals
Tarek Rabah
CEO Otsuka North America
Jake Auchincloss
Congressman Massachusetts
Susan Hockfield
President Emerita MIT
Bob Langer
Koch Professor, MIT
Co-Founder, Moderna
Phil Sharp
Nobelist
Koch, MIT
Co-Founder, Alnylam/Biogen
Jane Grogan
EVP, Head, Research Biogen
Jeff Legos
Chief Oncology Officer Pfizer
Fiona Marshall
President, BioMedical Research Novartis
Robert Plenge
Chief Research Officer Bristol Myers Squibb
David Weinreich
Global Head, R&D EMD Serono
Julian Adams
CEO Stand Up To Cancer
Annette Bakker
CEO Children's Tumor Foundation
Julie Gerberding
CEO, Foundation for the NIH former Director, CDC
Anne Klibanski
President & CEO Mass General Brigham
John O'Brien
CEO National Pharmaceutical Council
Bruno Gomes
Head, Early Clinical Development Oncology Roche
Matt Hefner
Global Head, BD Kyowa Kirin
Jean-Frédéric Paulsen
CEO Ferring Pharmaceuticals
Sarah Sheikh
Head, Global Development & SVP, Neuroscience Takeda
Issei Tsukamoto
SVP, Head, BD Astellas
Ari Brettman
Senior Managing Director Blackstone Life Science
Jeanne Cunicelli
President UPMC Enterprises
Ansbert Gadicke
Managing Partner MPM BioImpact
Rob Perez
Operating Partner, General Atlantic
Chair, Life Science Cares
Christoph Westphal
General Partner Longwood Fund
Kyle Lefkoff
General Partner Boulder Ventures
Ferran Prat
CCO, BostonGene
Gilmore O'Neill
CEO Editas Medicine
Shinji Okitsu
Head, Research Strategic Collaborations & Partnerships Sanofi
Stef van Grieken
CEO Cradle
Brad Margus
Chair, Cerevance
Chair, A-T Children’s Project
Bharat Tewarie
CEO Helio Genomics
Rehan Verjee
CEO Precede Bio
Judy Chou
CEO AltruBio
Ruxandra Draghia-Akli
Chair, Scientific Advisory Board, INTREPID Alliance
Kenneth Moch
CEO Regerna Therapeutics
Ming Wang
CEO Phanes Therapeutics
Raj Prasad
CFO, Crispr Therapeutics
Tim Noyes
CEO Newleos
Mike Rosenblatt
Senior Advisor, Flagship Pioneering
former CMO, Merck
Bill Heiden
Chair, Macrogenics
Manuel Aivado
CEO Stelexis
Rachel Humphrey
CEO Normunity
Samir Khleif
CEO Georgiamune
Yiannis Kiachopoulos
CEO Causaly
Andrew Baum
Senior Strategic Advisor Pfizer
John Butler
CEO Akebia Therapeutics
Chandra Ramanathan
EVP, Commercialization & Strategy, BRC Therapeutics
Reza Afkhami
CBO, Kamau Therapeutics
Jeff Aronin
CEO Paragon Biosciences
Sean McCarthy
CEO CytomX
Tim Ehrlich
Partner, Gunderson Dettmer
Partners on record
50 listedVenue & travel
Venue
Mandarin Oriental, BostonQuestions people ask
5 answeredBoston CEO 2026 starts on November 2, 2026.
Boston CEO 2026 takes place at Mandarin Oriental, Boston, in Boston, Massachusetts.
The organizer identifies BioPharma CEOs, research and development heads, life science investors, and leading academics as audience groups.
It is most useful for biopharma executives and life science investors who value closed-door conversation with peers, since the attendee base is CEOs, heads of R&D, investors and academics and the speakers include Thomas Schinecker of Roche, Marc Casper of Thermo Fisher Scientific and Bob Langer. The off-the-record format and the presence of Governor Maura Healey and Mayor Michelle Wu point to a policy and deal-making audience at the senior level. Early-career scientists, service vendors and anyone seeking technical or hands-on content would get less from it, as the attendee pool is senior and the focus is leadership conversation.
Executives and investors at a luxury-hotel biopharma gathering in Boston in November usually wear business formal or sharp business attire, such as suits or tailored separates, with a coat for the weather.
Related events
Find more events with this kind of reach.
We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.
Also listed in